![]()
27.08.20131713
We examined whether the severity of central sleep apnoea (CSA) and the level of C-reactive protein are associated with the prevalence and complexity of arrhythmias, and whether these factors contribute to increased risk of nocturnal sudden death.
![]()
26.08.20131662
Nonalcoholic fatty liver disease (NAFLD) is closely correlated with insulin resistance and several metabolic syndrome features, but whether it could increase the risk of cardiovascular disease remains undefined.
![]()
23.08.20131846
To assess long-term outcomes and the management of critical left-sided infective endocarditis (IE) and evaluate the impact of surgery.
![]()
22.08.20131715
To examine the prescribing patterns of medications quantified by the performance measures for acute myocardial infarction (AMI).
![]()
21.08.20131804
The ideal blood pressure (BP) to decrease mortality rates in patients with non–dialysis-dependent chronic kidney disease (CKD) is unclear.
![]()
20.08.20131780
Strikingly wide variation among patients in plasma levels of atorvastatin and rosuvastatin (Crestor, AstraZeneca), even with consistent dosing, is likely related to gene variants that affect the drugs' uptake by the liver in some patients, suggests a prospective study.
![]()
19.08.20131998
The first aim was to critically evaluate the extent to which familial hypercholesterolaemia (FH) is underdiagnosed and undertreated. The second aim was to provide guidance for screening and treatment of FH, in order to prevent coronary heart disease (CHD).
